FR2528837A1 - Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication - Google Patents

Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication Download PDF

Info

Publication number
FR2528837A1
FR2528837A1 FR8210630A FR8210630A FR2528837A1 FR 2528837 A1 FR2528837 A1 FR 2528837A1 FR 8210630 A FR8210630 A FR 8210630A FR 8210630 A FR8210630 A FR 8210630A FR 2528837 A1 FR2528837 A1 FR 2528837A1
Authority
FR
France
Prior art keywords
pyridazinone
och
derivatives
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8210630A
Other languages
English (en)
French (fr)
Other versions
FR2528837B1 (de
Inventor
Henri Chibret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPEUTIQUE APPLIC SA
Original Assignee
THERAPEUTIQUE APPLIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERAPEUTIQUE APPLIC SA filed Critical THERAPEUTIQUE APPLIC SA
Priority to FR8210630A priority Critical patent/FR2528837A1/fr
Priority to CH320483A priority patent/CH657125B/fr
Priority to NL8302087A priority patent/NL8302087A/nl
Priority to GR71641A priority patent/GR78284B/el
Priority to DE3321772A priority patent/DE3321772A1/de
Priority to GB08316516A priority patent/GB2122195A/en
Priority to BE0/211031A priority patent/BE897085A/fr
Priority to JP58108026A priority patent/JPS5910571A/ja
Priority to KR1019830002710A priority patent/KR860001339B1/ko
Priority to IT8321684A priority patent/IT1194281B/it
Publication of FR2528837A1 publication Critical patent/FR2528837A1/fr
Application granted granted Critical
Publication of FR2528837B1 publication Critical patent/FR2528837B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8210630A 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication Granted FR2528837A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication
CH320483A CH657125B (de) 1982-06-18 1983-06-10
NL8302087A NL8302087A (nl) 1982-06-18 1983-06-11 Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel.
GR71641A GR78284B (de) 1982-06-18 1983-06-13
DE3321772A DE3321772A1 (de) 1982-06-18 1983-06-16 Pyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
GB08316516A GB2122195A (en) 1982-06-18 1983-06-17 Pyridazinones
BE0/211031A BE897085A (fr) 1982-06-18 1983-06-17 Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication
JP58108026A JPS5910571A (ja) 1982-06-18 1983-06-17 医薬品として使用可能なピリダジノンの誘導体、及びそれの製造方法
KR1019830002710A KR860001339B1 (ko) 1982-06-18 1983-06-17 피리다지논 유도체의 제조방법
IT8321684A IT1194281B (it) 1982-06-18 1983-06-17 Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (2)

Publication Number Publication Date
FR2528837A1 true FR2528837A1 (fr) 1983-12-23
FR2528837B1 FR2528837B1 (de) 1984-12-07

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8210630A Granted FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Country Status (10)

Country Link
JP (1) JPS5910571A (de)
KR (1) KR860001339B1 (de)
BE (1) BE897085A (de)
CH (1) CH657125B (de)
DE (1) DE3321772A1 (de)
FR (1) FR2528837A1 (de)
GB (1) GB2122195A (de)
GR (1) GR78284B (de)
IT (1) IT1194281B (de)
NL (1) NL8302087A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0129791A2 (de) * 1983-06-20 1985-01-02 CASSELLA Aktiengesellschaft Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (de) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, volume 49, no. 4, avril 1976 (TOKYO, JP) T. SATO et al. "A convenient synthesis of beta-acetyl-gamma-substituted-gamma-butyrolactones and gamma-acetyl-delta-substituted-delta-valerolactones", pages 1055-1058 *
CHEMICAL ABSTRACTS, volume 72, no. 2, 12 janvier 1970, page 458, abrégé 9048r (COLUMBUS OHIO, US) & Suom. Kemistilehti B 1969, 42(7-8), 312-13, S. ESKOLA et al. "Thin-layer chromatographic study of some 3-methyl-6-pyridazinone derivatives" *
CHEMICAL ABSTRACTS, volume 95, no. 23, 7 décembre 1981, page 50, abrégé 197388y (COLUMBUS OHIO, US) & Ann. Pharm. Fr. 1981, 39(3), 215-22, PHAM HUU CHANH et al. "Cardiostimulant action and hemodynamic effects of a new beta-acetyl butyrolactone" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0129791A2 (de) * 1983-06-20 1985-01-02 CASSELLA Aktiengesellschaft Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0129791A3 (de) * 1983-06-20 1987-06-10 CASSELLA Aktiengesellschaft Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
CH657125B (de) 1986-08-15
KR860001339B1 (ko) 1986-09-15
IT1194281B (it) 1988-09-14
NL8302087A (nl) 1984-01-16
DE3321772A1 (de) 1983-12-22
IT8321684A0 (it) 1983-06-17
JPS5910571A (ja) 1984-01-20
FR2528837B1 (de) 1984-12-07
GR78284B (de) 1984-09-26
BE897085A (fr) 1983-12-19
GB8316516D0 (en) 1983-07-20
KR840005105A (ko) 1984-11-03
GB2122195A (en) 1984-01-11

Similar Documents

Publication Publication Date Title
EP0318377B1 (de) Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung
FR2501686A1 (fr) Nouveaux derives de 3,4-dihydro-5h-2,3-benzodiazepine, procede pour les preparer et medicaments les contenant
EP0352301A1 (de) Buttersäure-ester und ihre verwendung als arzneimittel
EP0067086A1 (de) Benzoxepinderivate und ihre Schwefel- und Stickstoffanaloge, Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel
EP0138721B1 (de) Benzensulfonyllactame, Verfahren zu ihrer Herstellung und ihre Anwendung als wirksame Bestandteile in pharmazeutischen Zusammensetzungen
FR2528837A1 (fr) Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication
EP0366511A1 (de) Benzoxazolinon-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP0239436B1 (de) Tricyclisches Derivat, nämlich 5-(3-Chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo[c,f] [1,2]-thiazepin-11-yl amino)-pentansäure, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
FR2577552A1 (fr) Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
CA2022732A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2570701A1 (fr) Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
EP0151140B1 (de) Salz von 2-piperazinopyrimidin, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammenstellungen
CA2045849A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2514006A1 (fr) Acylamino-4 aza-1 adamantanes, procede pour leur preparation, et application en therapeutique
EP0240398A1 (de) Dissymmetrische 1,4-Dihydropyridin-3,5-dicarbonsäure-Derivate, Verfahren zur Herstellung und Verwendung in Therapeutik
EP0094283B1 (de) Arzneimittelform von Theophyllin mit verlängerter Wirkung
WO1981002295A1 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant
FR2636065A1 (fr) Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
FR2526793A1 (fr) Nouveaux a-(n-pyrrolyl)-acides et leurs sels et esters, utiles comme medicaments et procede de la preparation de tels composes
CA1125743A (fr) Derives d'amino-3-cardenolides, procede pour leur preparation, et medicaments les contenant
FR2518537A1 (fr) Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant
FR2673105A1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
CA1191837A (fr) Procede de peparation de nouveaux agents carcinostatiques et medicaments ainsi obtenus
WO1999000390A1 (fr) Nouveaux derives tricycliques de benzimidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2708611A1 (fr) Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.

Legal Events

Date Code Title Description
ST Notification of lapse